CytomX Therapeutics, Inc. revenue breakdown overview

CytomX Therapeutics, Inc. revenue for the last year amounted to 138.10 M USD, the most of which — 138.10 M USD — came from its highest performing source at the moment, Probody Therapeutics, the year earlier bringing 101.21 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought CytomX Therapeutics, Inc. 138.10 M USD, and the year before that — 101.21 M USD.